CN105054041A - Fatigue preventing maca tablet - Google Patents
Fatigue preventing maca tablet Download PDFInfo
- Publication number
- CN105054041A CN105054041A CN201510559394.9A CN201510559394A CN105054041A CN 105054041 A CN105054041 A CN 105054041A CN 201510559394 A CN201510559394 A CN 201510559394A CN 105054041 A CN105054041 A CN 105054041A
- Authority
- CN
- China
- Prior art keywords
- fatigue
- parts
- maca
- antifatigue
- maca tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 240000000759 Lepidium meyenii Species 0.000 title claims abstract description 26
- 235000000421 Lepidium meyenii Nutrition 0.000 title claims abstract description 26
- 235000012902 lepidium meyenii Nutrition 0.000 title claims abstract description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 31
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 8
- 239000008101 lactose Substances 0.000 claims abstract description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 8
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 230000002929 anti-fatigue Effects 0.000 claims description 24
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 claims description 10
- 239000003755 preservative agent Substances 0.000 claims description 9
- 230000002335 preservative effect Effects 0.000 claims description 9
- HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 claims description 6
- UEPVWRDHSPMIAZ-IZTHOABVSA-N (1e,4z,6e)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-IZTHOABVSA-N 0.000 claims description 5
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 claims description 5
- 241000219780 Pueraria Species 0.000 claims description 5
- 229930016183 alpha-curcumene Natural products 0.000 claims description 5
- NMRUIRRIQNAQEB-UHFFFAOYSA-N demethoxycurcumin Natural products OC(=CC(C=CC1=CC(=C(C=C1)O)OC)=O)C=CC1=CC=C(C=C1)O NMRUIRRIQNAQEB-UHFFFAOYSA-N 0.000 claims description 5
- UEPVWRDHSPMIAZ-UHFFFAOYSA-N p-hydroxycinnamoyl feruloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(O)=CC(=O)C=CC=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-UHFFFAOYSA-N 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 4
- 229910052742 iron Inorganic materials 0.000 abstract description 4
- 239000011707 mineral Substances 0.000 abstract description 4
- 210000003205 muscle Anatomy 0.000 abstract description 4
- 239000011701 zinc Substances 0.000 abstract description 4
- 229910052725 zinc Inorganic materials 0.000 abstract description 4
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 208000007502 anemia Diseases 0.000 abstract description 3
- 210000000987 immune system Anatomy 0.000 abstract description 3
- 102000004169 proteins and genes Human genes 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 3
- 229960003080 taurine Drugs 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 2
- 208000035240 Disease Resistance Diseases 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 8
- 206010016256 fatigue Diseases 0.000 description 7
- 230000036541 health Effects 0.000 description 5
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 241000554155 Andes Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- MDKCFLQDBWCQCV-UHFFFAOYSA-N benzyl isothiocyanate Chemical compound S=C=NCC1=CC=CC=C1 MDKCFLQDBWCQCV-UHFFFAOYSA-N 0.000 description 2
- 235000012754 curcumin Nutrition 0.000 description 2
- 229940109262 curcumin Drugs 0.000 description 2
- 239000004148 curcumin Substances 0.000 description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035946 sexual desire Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010054196 Affect lability Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010067162 Asthenospermia Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000019229 Dinia Species 0.000 description 1
- 241001459693 Dipterocarpus zeylanicus Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010058359 Hypogonadism Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- QAADZYUXQLUXFX-UHFFFAOYSA-N N-phenylmethylthioformamide Natural products S=CNCC1=CC=CC=C1 QAADZYUXQLUXFX-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 240000001970 Raphanus sativus var. sativus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000003058 alpha-curcumene group Chemical group 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention discloses a fatigue preventing maca tablet which comprises the following raw materials in parts by weight: 100 parts of maca powder, 2-8 parts of microcrystalline cellulose, 0.5-2.5 parts of silica, and 1-5 parts of lactose. The fatigue preventing maca tablets contain a high amount of iron, protein, amino acids, mineral zinc, taurine and other ingredients, can obviously fight fatigue, increase muscle endurance, resist exercise-induced fatigue, help strengthen the immune system, enhance disease resistance of the body, prevent fatigue, enhance energy and physical strength, improve symptoms of anemia, and enable the skin to look younger, and the essence, qi and spirit to be fuller.
Description
Technical field
The present invention relates to a kind of Maca tablet, particularly relate to a kind of antifatigue Maca tablet.
Background technology
Agate coffee, formal name used at school: LepidiummeyeniiWalp, Spanish: Maca.Mainly producing in South America Andes and Chinese yunnan Lijing, is a kind of crucifer.Leaf is oval, and rhizome likeness in form turnip radish, edible is a kind of natural food, and nutrition is enriched, and has the reputation of " South America ginseng ".The hypocotyl of agate coffee may be golden or faint yellow, red, purple, blueness, black or green.Flaxen the most common, and shape, taste are also best.Agate coffee is rich in high unit nutrient, human body is had to the function of nourishing and fit keeping function.
Agate coffee originates in High aititude mountain area, is suitable for growing in High aititude, low latitudes, high day and night temperature, subacidity sandy loam, sun-drenched soil; Plantation area is mainly distributed in Andes, state, South America, and the Yulong Xueshan area of Chinese yunnan Lijing, and there is suitable kind of soil of larger area this two large main producing region.And also there is a small amount of plantation in other areas of Chinese yunnan and the area such as Xinjiang, Tibet.
Italian scientist DiniA has systematically drawn the chemical composition composition in the dry root of agate card first in 1994: protein content is more than 10% (protein content of the agate card kind of Hu Ning lakeside is more than 14%), the carbohydrate of 59%; The fiber of 8.5%, include the mineral matters such as abundant zinc, calcium, iron, titanium, rubidium, potassium, sodium, copper, manganese, magnesium, strontium, phosphorus, iodine, and containing vitamin C, B1, B2, B6, A, E, B12, B5, fat content is not high but mostly wherein be unrighted acid, the content of linoleic acid plus linolenic acid reaches more than 53%, and natural activity composition comprises alkaloid, glucosinolate and catabolite benzyl isothiocyanate, sterol, polyphenols etc.1999, American scientist has found vegetable active composition new containing two classes in agate card, macamides (macamides) He Maka rare (macaenes), and determine that these two kinds of materials have remarkable effect to balanced human's hormone secretion, the natural hormone engine so agate card is otherwise known as.In the specific aim research of agate card product, find again several special agate card alkaloid, along with going deep into of research, also had the activated novel substance of more tool in agate card and be isolated and identified.The Ministry of Public Health is national new resource food at approval agate coffee in 2011.
At present, the deep processed product of agate coffee is actually rare.
Summary of the invention
For the deficiencies in the prior art, technical problem to be solved by this invention is to provide a kind of antifatigue Maca tablet.
For achieving the above object, the technology used in the present invention solution is:
A kind of antifatigue Maca tablet, comprises following weight parts raw material: pueraria root powder 100 parts, microcrystalline cellulose 2-8 part, silica 0.5-2.5 part, lactose 1-5 part.
A kind of antifatigue Maca tablet, is made up of following weight parts raw material: pueraria root powder 100 parts, microcrystalline cellulose 2-8 part, silica 0.5-2.5 part, lactose 1-5 part, biological preservative 0.2-0.6 part.
Described biological preservative is α-curcumene and/or Demethoxycurcumin.
Described biological preservative is made up of the α-curcumene of 40-60wt% and the Demethoxycurcumin of 40-60wt%.
By agate coffee drying and crushing to 400-800 order, then mix with microcrystalline cellulose, silica, lactose and biological preservative, conventional common process compressing tablet, can obtain antifatigue Maca tablet of the present invention.
Concrete, in the present invention:
α-curcumene, No. CAS: 644-30-4.Demethoxycurcumin, No. CAS: 24939-17-1.Curcumin, No. CAS: 458-37-7.
Antifatigue Maca tablet of the present invention is containing the iron of higher amount; the compositions such as protein, amino acid, mineral matter zinc, taurine can obviously to antifatigue; strengthen muscular endurance; resisted movement fatigue; help firm immune system, promote body premunition, to antifatigue; strengthen energy, muscle power, improve Anemia.Make the colour of skin seem younger, energy is more sufficient.After interpolation biological preservative, the shelf-life is significantly extended.
Antifatigue Maca tablet of the present invention is suitable for crowd:
A: the male sex/erection often felt fatigue has obstacle person, hyposexuality person;
B: the often large and diet deviant of lassitude, the person of feeling depressed/operating pressure;
C: the adult male of the weak essence amount of asthenospermia rare person/suffer from hyperplasia of prostate.
Antifatigue Maca tablet of the present invention is suitable for symptom:
A: the reduction of hypogona dism, sexual desire, energy, muscle power, notice, failure of memory, easily tired, appetite goes down, constipation, enuresis nocturna number of times increase etc.
B: periodicity headache, palpitaition, uncomfortable in chest, unsmooth breath, tinnitus, mono-anesthesia etc.Easy agitation, irritability, suspicious, feeling of terror, feeling of lonely, interest attenuating etc.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described further.Everyly do not depart from the present invention program's content, any simple modification done following examples according to technical spirit of the present invention or equivalent variations, all drop in protection scope of the present invention.
Embodiment 1-6:
By agate coffee drying and crushing to 800 order, then mix with microcrystalline cellulose, silica, lactose and biological preservative, conventional common process compressing tablet, can obtain antifatigue Maca tablet of the present invention.
Table 1: antifatigue Maca tablet formula table unit: gram
| Raw material | Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | Embodiment 6 |
| Pueraria root powder | 100 | 100 | 100 | 100 | 100 | 100 |
| Microcrystalline cellulose | 5 | 5 | 5 | 5 | 5 | 5 |
| Silica | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 |
| Lactose | 3 | 3 | 3 | 3 | 3 | 3 |
| α-curcumene | 0.2 | 0.4 | - | - | - | 0.2 |
| Demethoxycurcumin | 0.2 | - | 0.4 | - | - | - |
| Curcumin | - | - | - | - | 0.4 | 0.2 |
Test case 1:
The Double-blind randomized clinical trial carried out in 60 20-60 year healthy male subjects, is divided into two groups by experimenter.
First group: every day per os hora somni 5 0.5 gram/piece embodiment 1 antifatigue Maca tablet, after taking one month continuously, test.
Second group, be blank group, refer to and do not use antifatigue Maca tablet of the present invention and other similar health products.
Result shows: after one month, and first group of crowd's sexual desire is significantly higher than second group.Illustrate that antifatigue Maca tablet of the present invention can improve Male sexual wish.
The antifatigue Maca tablet effect performance of embodiments of the invention 1:
A:10-20 days: the tired phenomenon not good with energy of health has clear improvement, and sleep quality takes a turn for the better, indefatigability.
B:30-40 days: gather colour, memory takes a turn for the better, and obviously improves phenomenon that is slow in reacting and difficult concentrating; Have a pain in the back improvement, life quality is significantly improved.
C:40-60 days: skin recovers gloss, energy is more abundant, and phychology is positive, and eliminate sleep-disorder, the resistance against diseases of health obviously strengthens, and life quality is higher, no longer includes the tired sense after sexual life.
D:60-120 days: the effect consolidating second round, nurses one's health body and mind comprehensively.The physiological function degeneration caused because of fatigue obtains basic change with the situation of emotional lability, and the every physical signs of health is the young healthy state as 25 years old.
Test case 2:
Often organize 100 animals.Take the antifatigue Maca tablet 1.25g of embodiment 1, respectively add pure water to 100mL, be made into 12.5mg/mL strength solution.
Adopt administration by gavage, every day gives tested material with the volume of 0.2mL/10gBW, negative control group gives equal-volume pure water, after continuous 30d, the method of inspection with reference to alleviating physical fatigue functional experiment in the Ministry of Public Health " health food inspection and assessment technical specification-2003 " detects the walking weight load of test mice, serum urea, hepatic glycogen, averages.Test data is in table 2.
Table 2: alleviating physical fatigue functional experiment table
Test proves: antifatigue Maca tablet of the present invention is containing the iron of higher amount; the compositions such as protein, amino acid, mineral matter zinc, taurine can obviously to antifatigue; strengthen muscular endurance; resisted movement fatigue; help firm immune system, promote body premunition, to antifatigue; strengthen energy, muscle power, improve Anemia.Make the colour of skin seem younger, energy is more sufficient.
Test case 3:
By the antifatigue Maca tablet of embodiment 1-6, be placed in 28 DEG C, preservation half a year under relative humidity 85% environment, adopt " GB/T4789.2-2010 microbiological test of food hygiene total plate count mensuration " to carry out total plate count test.Concrete test result, in table 3.
Table 3: total plate count test chart
| Total plate count, cfu/g | |
| Embodiment 1 | 1.6×10 4 |
| Embodiment 2 | 2.4×10 4 |
| Embodiment 3 | 3.2×10 4 |
| Embodiment 4 | 3.1×10 5 |
| Embodiment 5 | 4.6×10 4 |
| Embodiment 6 | 3.7×10 4 |
After interpolation biological preservative, total plate count obviously declines, and shelf life of products is significantly extended.
Claims (2)
1. an antifatigue Maca tablet, is characterized in that, is made up of following weight parts raw material: pueraria root powder 100 parts, microcrystalline cellulose 2-8 part, silica 0.5-2.5 part, lactose 1-5 part.
2. an antifatigue Maca tablet, is characterized in that, is made up of following weight parts raw material: pueraria root powder 100 parts, microcrystalline cellulose 2-8 part, silica 0.5-2.5 part, lactose 1-5 part, biological preservative 0.2-0.6 part;
Described biological preservative is made up of 40-60wt% α-curcumene and 40-60wt% Demethoxycurcumin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510559394.9A CN105054041A (en) | 2015-09-02 | 2015-09-02 | Fatigue preventing maca tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510559394.9A CN105054041A (en) | 2015-09-02 | 2015-09-02 | Fatigue preventing maca tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105054041A true CN105054041A (en) | 2015-11-18 |
Family
ID=54483764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510559394.9A Withdrawn CN105054041A (en) | 2015-09-02 | 2015-09-02 | Fatigue preventing maca tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105054041A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106344774A (en) * | 2016-09-25 | 2017-01-25 | 安徽旺润生物科技有限公司 | Black garlic and mair conditioning unita tablets |
| CN107638481A (en) * | 2017-09-30 | 2018-01-30 | 魏春艳 | Antifatigue lozenge and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102823798A (en) * | 2012-09-11 | 2012-12-19 | 山东益宝生物制品有限公司 | Maca tablet and preparation method thereof |
| CN103238842A (en) * | 2013-05-21 | 2013-08-14 | 天津兰瑞生物技术有限公司 | Limulus egg and maca health-care tablets and preparation method thereof |
| CN103652927A (en) * | 2013-12-30 | 2014-03-26 | 重庆喜旋生物科技有限公司 | Dispersible tablet of maca, preparation method and application thereof |
| CN104664386A (en) * | 2015-03-19 | 2015-06-03 | 沈阳伊人宝生化制品有限公司 | Ultra-micronized powder maca tablet |
| CN104687048A (en) * | 2015-03-09 | 2015-06-10 | 江苏慧博生物科技有限公司 | Maca tablet and preparation method thereof |
-
2015
- 2015-09-02 CN CN201510559394.9A patent/CN105054041A/en not_active Withdrawn
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102823798A (en) * | 2012-09-11 | 2012-12-19 | 山东益宝生物制品有限公司 | Maca tablet and preparation method thereof |
| CN103238842A (en) * | 2013-05-21 | 2013-08-14 | 天津兰瑞生物技术有限公司 | Limulus egg and maca health-care tablets and preparation method thereof |
| CN103652927A (en) * | 2013-12-30 | 2014-03-26 | 重庆喜旋生物科技有限公司 | Dispersible tablet of maca, preparation method and application thereof |
| CN104687048A (en) * | 2015-03-09 | 2015-06-10 | 江苏慧博生物科技有限公司 | Maca tablet and preparation method thereof |
| CN104664386A (en) * | 2015-03-19 | 2015-06-03 | 沈阳伊人宝生化制品有限公司 | Ultra-micronized powder maca tablet |
Non-Patent Citations (1)
| Title |
|---|
| 齐莉莉等: "姜黄提取物的抗氧化及抗菌活性研究", 《中国调味品》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106344774A (en) * | 2016-09-25 | 2017-01-25 | 安徽旺润生物科技有限公司 | Black garlic and mair conditioning unita tablets |
| CN107638481A (en) * | 2017-09-30 | 2018-01-30 | 魏春艳 | Antifatigue lozenge and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE102015100923A1 (en) | Integrated nutritional powder and process for its preparation | |
| CN102172269B (en) | Hidegelatin fabricated food with beautification function | |
| CN101548731B (en) | Commercial pig green feed | |
| CN104432035B (en) | The health nutrient composition and method of making the same of enhancing immunity and application | |
| CN102349608A (en) | Healthcare product combination for clearing and nourishing throat and preparation method thereof | |
| CN101642251B (en) | Nutritive rice suitable for middle-aged and elderly people and processing method thereof | |
| CN105819967A (en) | Nutrient rich in selenium and iodine, preparing method thereof and method for cultivating tomato rich in selenium and iodine | |
| CN105054041A (en) | Fatigue preventing maca tablet | |
| CN105105120A (en) | Maca healthcare product | |
| CN105029420A (en) | Maca moringa tablet | |
| CN105028845A (en) | Maca health protection tea | |
| CN105994740A (en) | Green tea with dendrobium officinale and method for preparing green tea | |
| CN106107070A (en) | A kind of Chinese herbal medicine feed for goat and preparation method thereof | |
| CN105077418A (en) | Maca soup and preparation method thereof | |
| KR20190118720A (en) | Functional and eco-friendly adjuvants for pig feeds based on black tea mugwort, and its production method, pig breeding method and the pork making thereof | |
| CN108497169A (en) | A kind of livestock and poultry Chinese herb feed additive and preparation method thereof | |
| CN103933146A (en) | Pollen product capable of adjusting human body immunity | |
| CN104161171B (en) | A kind of Chinese medicinal herb pig feed | |
| CN106820123A (en) | A kind of traditional Chinese medicinal meals baking soda and preparation method thereof | |
| CN104256821B (en) | A kind of agate coffee compound oral liquid and preparation method thereof | |
| CN102715609A (en) | High-energy nutrient composition | |
| CN105918586A (en) | Making technology of Maca tablets | |
| CN105768093A (en) | Maca tablets | |
| CN105191859A (en) | Production method of low-cholesterol potassium-rich carotene-rich egg | |
| CN111228408A (en) | Penis cervi, ginseng and oyster soft capsule for enhancing male sexual function and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20151118 |